Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation

被引:32
作者
Ariztia, EV
Subbarao, V
Solt, DB
Rademaker, AW
Iyer, AP
Oltvai, ZN
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
关键词
hepatocyte growth factor; osteopontin; tumor growth; invasiveness; metastasis;
D O I
10.1016/S0014-4827(03)00118-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cytokine hepatocyte growth factor (HGF)/scatter factor-1 and its cognate receptor, Met, are involved in the etiology and progression of many types of cancer. Despite recent advances in understanding the signal transduction pathways activated by HGF, the mechanism by which HGF exerts its tumorigenic effect is not well understood. To identify proteins that may be involved in mediating HGF-induced cell motility, invasiveness, and tumorigenesis, we used two separate differential display screening methods to identify changes in gene expression that are initiated by HGF in an epithelial cell culture system. Among several known and unknown genes whose expression was modified, osteopontin (OPN), a protein previously associated with tumorigenesis, was found to be upregulated. within 6 h following HGF stimulation. OPN expression was dependent on activation of the PI-3 kinase pathway. Autocrine secretion of HGF resulted in sustained expression of OPN. Downregulation of opn expression by stable antisense transfection attenuated OPN expression and repressed HGF-induced invasiveness in vitro and decreased HGF-mediated tumor growth and metastasis formation in vivo. Constitutive expression of OPN in itself exerted partial invasiveness in vitro, but its expression itself was not sufficient to initiate tumor growth or metastasis formation in vivo. Thus, together with other molecules, OPN activity contributes to HGF-induced tumor growth and invasiveness. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:257 / 267
页数:11
相关论文
共 49 条
  • [1] Adachi T, 1996, HEPATOLOGY, V24, P1274
  • [2] ALBINI A, 1987, CANCER RES, V47, P3239
  • [3] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [4] Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
    Bardelli, A
    Longati, P
    Gramaglia, D
    Basilico, C
    Tamagnone, L
    Giordano, S
    Ballinari, D
    Michieli, P
    Comoglio, PM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) : 14379 - 14383
  • [5] BEHREND EI, 1994, CANCER RES, V54, P832
  • [6] Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
    Birchmeier, C
    Gherardi, E
    [J]. TRENDS IN CELL BIOLOGY, 1998, 8 (10) : 404 - 410
  • [7] Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
    Boccaccio, C
    Andò, M
    Tamagnone, L
    Bardelli, A
    Michieli, P
    Battistini, C
    Comoglio, PM
    [J]. NATURE, 1998, 391 (6664) : 285 - 288
  • [8] Osteopontin expression in lung cancer
    Chambers, AF
    Wilson, SM
    Kerkvliet, N
    OMalley, FP
    Harris, JF
    Casson, AG
    [J]. LUNG CANCER, 1996, 15 (03) : 311 - 323
  • [9] Insights into the structure of hepatocyte growth factor scatter factor (HGF/SF) and implications for receptor activation
    Chirgadze, DY
    Hepple, J
    Byrd, RA
    Sowdhamini, R
    Blundell, TL
    Gherardi, E
    [J]. FEBS LETTERS, 1998, 430 (1-2): : 126 - 129
  • [10] IDENTIFICATION OF THE MAJOR PHOSPHOPROTEIN SECRETED BY MANY RODENT CELL-LINES AS 2AR/OSTEOPONTIN - ENHANCED EXPRESSION IN H-RAS-TRANSFORMED 3T3 CELLS
    CRAIG, AM
    NEMIR, M
    MUKHERJEE, BB
    CHAMBERS, AF
    DENHARDT, DT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (01) : 166 - 173